scispace - formally typeset
Search or ask a question

Showing papers by "Philip A. Beachy published in 2003"


Journal ArticleDOI
23 Oct 2003-Nature
TL;DR: A wide range of digestive tract tumours, including most of those originating in the oesophagus, stomach, biliary tract and pancreas, but not in the colon, display increased Hh pathway activity, which is suppressible by cyclopamine, a Hh pathways antagonist.
Abstract: Activation of the Hedgehog (Hh) signalling pathway by sporadic mutations or in familial conditions such as Gorlin's syndrome is associated with tumorigenesis in skin, the cerebellum and skeletal muscle. Here we show that a wide range of digestive tract tumours, including most of those originating in the oesophagus, stomach, biliary tract and pancreas, but not in the colon, display increased Hh pathway activity, which is suppressible by cyclopamine, a Hh pathway antagonist. Cyclopamine also suppresses cell growth in vitro and causes durable regression of xenograft tumours in vivo. Unlike in Gorlin's syndrome tumours, pathway activity and cell growth in these digestive tract tumours are driven by endogenous expression of Hh ligands, as indicated by the presence of Sonic hedgehog and Indian hedgehog transcripts, by the pathway- and growth-inhibitory activity of a Hh-neutralizing antibody, and by the dramatic growth-stimulatory activity of exogenously added Hh ligand. Our results identify a group of common lethal malignancies in which Hh pathway activity, essential for tumour growth, is activated not by mutation but by ligand expression.

1,297 citations


Journal ArticleDOI
20 Mar 2003-Nature
TL;DR: It is proposed that some types of SCLC might recapitulate a critical, Hh-regulated event in airway epithelial differentiation, and a common lethal malignancy that may respond to pharmacological blockade of the Hh signalling pathway is identified.
Abstract: Embryonic signalling pathways regulate progenitor cell fates in mammalian epithelial development and cancer. Prompted by the requirement for sonic hedgehog (Shh) signalling in lung development, we investigated a role for this pathway in regeneration and carcinogenesis of airway epithelium. Here we demonstrate extensive activation of the hedgehog (Hh) pathway within the airway epithelium during repair of acute airway injury. This mode of Hh signalling is characterized by the elaboration and reception of the Shh signal within the epithelial compartment, and immediately precedes neuroendocrine differentiation. We reveal a similar pattern of Hh signalling in airway development during normal differentiation of pulmonary neuroendocrine precursor cells, and in a subset of small-cell lung cancer (SCLC), a highly aggressive and frequently lethal human tumour with primitive neuroendocrine features. These tumours maintain their malignant phenotype in vitro and in vivo through ligand-dependent Hh pathway activation. We propose that some types of SCLC might recapitulate a critical, Hh-regulated event in airway epithelial differentiation. This requirement for Hh pathway activation identifies a common lethal malignancy that may respond to pharmacological blockade of the Hh signalling pathway.

1,084 citations


Journal ArticleDOI
28 Mar 2003-Science
TL;DR: This work used RNA interference and a quantitative cultured cell assay to systematically screen functional roles of all kinases and phosphatases and subsequently 43% of predicted Drosophila genes were identified as Hh pathway components.
Abstract: Classical genetic screens can be limited by the selectivity of mutational targeting, the complexities of anatomically based phenotypic analysis, or difficulties in subsequent gene identification. Focusing on signaling response to the secreted morphogen Hedgehog (Hh), we used RNA interference (RNAi) and a quantitative cultured cell assay to systematically screen functional roles of all kinases and phosphatases, and subsequently 43% of predicted Drosophila genes. Two gene products reported to function in Wingless (Wg) signaling were identified as Hh pathway components: a cell surface protein (Dally-like protein) required for Hh signal reception, and casein kinase 1α, a candidate tumor suppressor that regulates basal activities of both Hh and Wg pathways. This type of cultured cell–based functional genomics approach may be useful in the systematic analysis of other biological processes.

550 citations


Journal ArticleDOI
TL;DR: It is reported that response to the Hh signal is compromised in mutant cells from mouse models of SLOS and lathosterolosis and in normal cells pharmacologically depleted of sterols, and that sterol depletion affects the activity of Smoothened (Smo), an essential component of the HH signal transduction apparatus.
Abstract: Smith-Lemli-Opitz syndrome (SLOS), desmosterolosis and lathosterolosis are human syndromes caused by defects in the final stages of cholesterol biosynthesis. Many of the developmental malformations in these syndromes occur in tissues and structures whose embryonic patterning depends on signaling by the Hedgehog (Hh) family of secreted proteins. Here we report that response to the Hh signal is compromised in mutant cells from mouse models of SLOS and lathosterolosis and in normal cells pharmacologically depleted of sterols. We show that decreasing levels of cellular sterols correlate with diminishing responsiveness to the Hh signal. This diminished response occurs at sterol levels sufficient for normal autoprocessing of Hh protein, which requires cholesterol as cofactor and covalent adduct. We further find that sterol depletion affects the activity of Smoothened (Smo), an essential component of the Hh signal transduction apparatus.

373 citations


Journal ArticleDOI
TL;DR: Evidence is presented that Smo associates directly with a Ci-containing complex that is scaffolded and stabilized by the atypical kinesin, Costal-2 (Cos2), which constitutively suppresses pathway activity, but Hh signaling reverses its regulatory effect to promote Ci-mediated transcription.

262 citations



Patent
20 May 2003
TL;DR: In this article, sterol-modified hedgehog polypeptides and functional fragments thereof were used to identify compositions which affect hedgehog activity based on inhibition of cholesterol modification of hedgehog protein.
Abstract: The present invention sterol-modified hedgehog polypeptides and functional fragments thereof Methods of identifying compositions which affect hedgehog activity based on inhibition of cholesterol modification of hedgehog protein are described In one aspect of the invention, the method provides a means for affecting cholesterol biosynthesis or transport in a cell comprising contacting a cell with an effective amount of a compound that affects hedgehog, thereby affecting cholesterol biosynthesis or transport The effect may be inhibition or stimulation of cholesterol biosynthesis or transport

6 citations




Patent
22 Apr 2003
TL;DR: The authors concerne des methodes et des reactifs pouvant inhiber des etats de croissance aberrante resultant d'un gain de fonction hedgehog, d'une perte de Fonction ptc ou de FONction de la proteine Smoothened.
Abstract: La presente invention concerne des methodes et des reactifs pouvant inhiber des etats de croissance aberrante resultant d'un gain de fonction hedgehog, d'une perte de fonction ptc ou d'un gain de fonction de la proteine Smoothened. Ces methodes consistent a placer la cellule au contact d'un antagoniste hedgehog, tel qu'une petite molecule, en quantite suffisante pour inhiber l'etat de croissance aberrante, par exemple pour induire une reaction agoniste d'une voie ptc normale ou antagoniste de l'activite de la proteine Smoothened ou de hedgehog. Les methodes et les reactifs de l'invention peuvent egalement inhiber la voie hedgehog dans des cellules saines, par exemple lorsque des niveaux normaux du signal hedgehog ne sont pas desires.